Compare GeneDx Holdings Corp (WGS) vs Zscaler Inc (ZS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Zscaler Inc — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while Zscaler Inc trades at $148.21 (market cap $24.23B). The key difference: Zscaler Inc is far larger — about 13.5× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.
| WGS | ZS | |
|---|---|---|
Market Cap | $1.80B | $24.23B |
Sector | Technology | Technology |
52-Week High | $167.51 | $336.27 |
52-Week Low | $34.51 | $118.05 |
Enterprise Value | $1.80B | $22.55B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Zscaler Inc
Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →
